Lam Research Corporation (NASDAQ) represented a move of -0.32 percent or $0.610000000000014 per share and closed its previous day trading session at $188.51. 2.79 Million Shares were traded in the last trading session with an Average Volume of 2.68 Million Shares. The stock currently has a Market Capitalization of 30.57 Billion.
Lam Research Corporation enables its customers to shape the future of technology by providing market-leading equipment and services for semiconductor wafer processing. To produce the tiny, complex chips used in products such as cell phones, computing devices, and entertainment gadgets, semiconductor manufacturers require highly sophisticated processes and equipment. Lam’s products play a key role in this, allowing chipmakers to build device features that are more than 1,000 times smaller than a grain of sand. Lam’s market-leading products are used in several steps that are repeated multiple times throughout the chip-making process, including thin film deposition, plasma etch, photoresist strip, and wafer cleaning. Their success as a company is based on a solid foundation of technical achievement, close collaboration with our customers, and delivering on commitments.
The stock traded between $108.46 and $219.70 over 1-Year time period showing its price to sales ratio of 3.45. Lam Research Corporation (NASDAQ) has currently no 20-Days Volatility trend.
Right now, the stock has a 50-Day Simple Moving Average of $-4.23 and 200-Day Simple Moving Average of $11.64. Its Price to Free Cash Flow is 15.51 and Price to Book of 4.2.
Analyst’s recommended the stock as 1.9 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Lam Research Corporation (NASDAQ) reported its Actual EPS of $3.46/share. The analysts offering Earnings Estimates for the company were believing that Lam Research Corporation could bring EPS of $3.28/share. The difference between Actual EPS and Estimated EPS was 0.18 Percent. Thus showing an Earnings Surprise of 5.5 Percent.
22nd Century Group, Inc. (NYSE)
In the last trading session, 22nd Century Group, Inc. (NYSE) added its value by 0.91% closing at the price of $3.34. The stock currently has market capitalization of 401.1 Million, with average volume of 3.34 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently 22nd Century Group, Inc. (NYSE) is showing beta of 3.07. This particular value of beta suggests that 22nd Century Group, Inc. (NYSE) has historically moved 307% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for 22nd Century Group, Inc. (NYSE) is at $-0.13.
The stock currently has RSI of 66.14. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
22nd Century Group, Inc. is a plant biotechnology company focused on decreasing/increasing the level of nicotine in the tobacco plant through genetic engineering and breeding. The Company is focused on development of smoking cessation aid and owns and controls several patents. The company’s products include X-22, a prescription smoking cessation aid, which is a tobacco-based botanical medical product for use as a smoking cessation therapy. 22nd Century Group, Inc. is based in Williamsville, New York.
22nd Century Group, Inc. (NYSE) topped its 52-week high price of $3.55 on 01/08/18 and 52-Week Low Price of $0.85 on 02/10/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 8.35% and monthly volatility of 8.07% respectively.